Biocon is confident about recovering from its 'sharp, unexpected fall' amid the pandemic

Despite disruptions to Biocon's growth and its Biologics' operations following a "sharp, unexpected fall," the biopharmaceutical company is confident it will recover from the coronavirus pandemic, and will "start pushing growth" in its second quarter, says executive chairperson Kiran Mazumdar-Shaw.
Tue, May 19 20203:00 AM EST